|
Maximum flexibility and increased production capacity will
be achieved by combining stirred tank with tried and tested
perfusion technology that will realise a minimum of a 20-fold
increase in productivity per vessel. This will ensure that
Alpha Biologics is able to produce as much mammalian cell
secreted protein as needed for any phase of pre-clinical and
clinical trials. We will also have the capacity and capability
to produce early market material for some products.
|
